Evelo Biosciences, Inc.
Pharmaceutical company · Foxboro, Massachusetts, United States
Evelo Biosciences, Inc. is a pharmaceutical company headquartered in Foxboro, Massachusetts, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $82 million sold in a notice filed in 2018.
Evelo Biosciences at a glance
What does Evelo Biosciences do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $81.5 million sold (2018).
Frequently asked questions about Evelo Biosciences
Where is Evelo Biosciences headquartered?
Evelo Biosciences, Inc. is headquartered in Foxboro, Massachusetts, United States.
What does Evelo Biosciences do?
Evelo Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Evelo Biosciences founded?
The earliest incorporation on record for Evelo Biosciences, Inc. is in 2014, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences